These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
271 related items for PubMed ID: 8975893
1. Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A Streptococcus. Moses AE, Wessels MR, Zalcman K, Albertí S, Natanson-Yaron S, Menes T, Hanski E. Infect Immun; 1997 Jan; 65(1):64-71. PubMed ID: 8975893 [Abstract] [Full Text] [Related]
2. Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Wessels MR, Moses AE, Goldberg JB, DiCesare TJ. Proc Natl Acad Sci U S A; 1991 Oct 01; 88(19):8317-21. PubMed ID: 1656437 [Abstract] [Full Text] [Related]
3. Effects on virulence of mutations in a locus essential for hyaluronic acid capsule expression in group A streptococci. Wessels MR, Goldberg JB, Moses AE, DiCesare TJ. Infect Immun; 1994 Feb 01; 62(2):433-41. PubMed ID: 8300204 [Abstract] [Full Text] [Related]
4. Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci. Dale JB, Washburn RG, Marques MB, Wessels MR. Infect Immun; 1996 May 01; 64(5):1495-501. PubMed ID: 8613352 [Abstract] [Full Text] [Related]
5. Critical role of the group A streptococcal capsule in pharyngeal colonization and infection in mice. Wessels MR, Bronze MS. Proc Natl Acad Sci U S A; 1994 Dec 06; 91(25):12238-42. PubMed ID: 7991612 [Abstract] [Full Text] [Related]
6. Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus. Levin JC, Wessels MR. Mol Microbiol; 1998 Oct 06; 30(1):209-19. PubMed ID: 9786197 [Abstract] [Full Text] [Related]
7. Expression of both M protein and hyaluronic acid capsule by group A streptococcal strains results in a high virulence for chicken embryos. Schmidt KH, Günther E, Courtney HS. Med Microbiol Immunol; 1996 Feb 06; 184(4):169-73. PubMed ID: 8811648 [Abstract] [Full Text] [Related]
8. M protein and hyaluronic acid capsule are essential for in vivo selection of covRS mutations characteristic of invasive serotype M1T1 group A Streptococcus. Cole JN, Pence MA, von Köckritz-Blickwede M, Hollands A, Gallo RL, Walker MJ, Nizet V. mBio; 2010 Aug 31; 1(4):. PubMed ID: 20827373 [Abstract] [Full Text] [Related]
9. Role of group A streptococcal virulence factors in adherence to keratinocytes. Darmstadt GL, Mentele L, Podbielski A, Rubens CE. Infect Immun; 2000 Mar 31; 68(3):1215-21. PubMed ID: 10678929 [Abstract] [Full Text] [Related]
10. Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. Ashbaugh CD, Warren HB, Carey VJ, Wessels MR. J Clin Invest; 1998 Aug 01; 102(3):550-60. PubMed ID: 9691092 [Abstract] [Full Text] [Related]
11. Capsular Polysaccharide of Group A Streptococcus. Wessels MR. Microbiol Spectr; 2019 Jan 01; 7(1):. PubMed ID: 30632480 [Abstract] [Full Text] [Related]
12. Capsule-deficient group A Streptococcus evades autophagy-mediated killing in macrophages. Shi Y-A, Lu S-L, Noda T, Chiu C-H, Chiang-Ni C. mBio; 2024 Jul 17; 15(7):e0077124. PubMed ID: 38819157 [Abstract] [Full Text] [Related]
13. Absence of a cysteine protease effect on bacterial virulence in two murine models of human invasive group A streptococcal infection. Ashbaugh CD, Wessels MR. Infect Immun; 2001 Nov 17; 69(11):6683-8. PubMed ID: 11598038 [Abstract] [Full Text] [Related]
14. M protein expression is not required for resistance to phagocytosis of type 18 group A streptococci. Liu S, Courtney HS, Bessen DE, Hasty DL, Dale JB. Adv Exp Med Biol; 1997 Nov 17; 418():725-7. PubMed ID: 9331754 [No Abstract] [Full Text] [Related]
15. Hyaluronic acid capsule modulates M protein-mediated adherence and acts as a ligand for attachment of group A Streptococcus to CD44 on human keratinocytes. Schrager HM, Albertí S, Cywes C, Dougherty GJ, Wessels MR. J Clin Invest; 1998 Apr 15; 101(8):1708-16. PubMed ID: 9541502 [Abstract] [Full Text] [Related]
16. An M protein with a single C repeat prevents phagocytosis of Streptococcus pyogenes: use of a temperature-sensitive shuttle vector to deliver homologous sequences to the chromosome of S. pyogenes. Perez-Casal J, Price JA, Maguin E, Scott JR. Mol Microbiol; 1993 May 15; 8(5):809-19. PubMed ID: 8355608 [Abstract] [Full Text] [Related]
17. Studies on the pathogenicity of group A streptococci. II. The antiphagocytic effects of the M protein and the capsular gel. FOLEY MJ, WOOD WB. J Exp Med; 1959 Oct 01; 110(4):617-28. PubMed ID: 13823728 [Abstract] [Full Text] [Related]
18. High-frequency intracellular infection and erythrogenic toxin A expression undergo phase variation in M1 group A streptococci. Cleary PP, McLandsborough L, Ikeda L, Cue D, Krawczak J, Lam H. Mol Microbiol; 1998 Apr 01; 28(1):157-67. PubMed ID: 9593304 [Abstract] [Full Text] [Related]
19. Upregulation of capsule enables Streptococcus pyogenes to evade immune recognition by antigen-specific antibodies directed to the G-related alpha2-macroglobulin-binding protein GRAB located on the bacterial surface. Dinkla K, Sastalla I, Godehardt AW, Janze N, Chhatwal GS, Rohde M, Medina E. Microbes Infect; 2007 Jul 01; 9(8):922-31. PubMed ID: 17544803 [Abstract] [Full Text] [Related]
20. A two-component regulatory system, CsrR-CsrS, represses expression of three Streptococcus pyogenes virulence factors, hyaluronic acid capsule, streptolysin S, and pyrogenic exotoxin B. Heath A, DiRita VJ, Barg NL, Engleberg NC. Infect Immun; 1999 Oct 01; 67(10):5298-305. PubMed ID: 10496909 [Abstract] [Full Text] [Related] Page: [Next] [New Search]